Pathologic Stage IIID Cutaneous Melanoma AJCC v8 trials recruiting in Washington

Fewer than 3 recruiting trials found.

All Pathologic Stage IIID Cutaneous Melanoma AJCC v8 trials nationally

Cities in Washington

Recruiting trials in Washington

• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
  NCT05098210 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle